Jane Street’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
Other funds holding EBS
OHA
Jane Street's EBS Position: Q2 2026 in Review
Jane Street sold out of Emergent Biosolutions (EBS) in Q2 2026, closing a stake of 117,315 shares — an estimated $982K sold.
Jane Street first reported a position in EBS in Q3 2013 and held it in 28 quarters. The position peaked at $4.89M in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.
- Jane Street reported no remaining Emergent Biosolutions position as of Q2 2026 after selling out during the quarter.
- Jane Street sold 117,315 Emergent Biosolutions shares in Q2 2026, an estimated $982K.
- Jane Street first reported a position in Emergent Biosolutions in Q3 2013 and held it in 28 quarters.
- Jane Street's Emergent Biosolutions position peaked at $4.89M in Q4 2025.
- 194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.